$LLY
AI分析生成日 May 18, 2026
AI Score
Buy$LLY
Eli Lilly and Company
$LLYNYSEHealthcareMega-Cap
Eli Lilly discovers, develops, and markets pharmaceutical products for endocrinology, oncology, and immunology worldwide.
Market Cap
$850B
Revenue (TTM)
$48.5B
+32.8%
Net Income (TTM)
$12.8B
+45.5%
EPS (TTM)
$14.25
P/E Ratio
62.5
Dividend Yield
0.6%
52-Week Range
$680-$980
Beta
0.42
Dimension Scores
Fundamental
80Technical
72Sentiment
80Risk / Reward
74Momentum
70Financial Health
Profitability
82strong
Growth
92strong
Liquidity
78moderate
Solvency
70moderate
Efficiency
75moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $LLY
Free · No credit card required
免責事項: AI生成の分析は教育目的のみです。投資アドバイスではありません。必ず資格のあるファイナンシャルアドバイザーにご相談ください。